Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lane

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
International Orthopaedics|April 23, 2013
Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysisAllison J Rao, Stefan Zwingenberger, Roberto Valladares, et al.
Journal of Medicinal Chemistry|October 22, 2013
A structure-activity analysis of biased agonism at the dopamine D2 receptorJeremy Shonberg, Carmen Klein Herenbrink, Laura López, et al.
Transfusion|September 24, 2004
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaLily Lin, Roberta Dikeman, Barbara Molini, et al.
The Journal of Biological Chemistry|February 12, 2010
Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residuesVeli-Pekka Jaakola, J Robert Lane, Judy Y Lin, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
Journal of Medicinal Chemistry|December 31, 2025
Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide ReceptorGeorge J Farmer, Julie Sanchez, Annabell Millns, et al.
Nature Communications|October 4, 2017
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D<sub>2</sub> receptorsDavid A Sykes, Holly Moore, Lisa Stott, et al.
European Urology Focus|November 10, 2019
Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_ScoreNiranjan J Sathianathen, Robert Lane, Benjamin Condon, et al.
Molecular Pharmacology|September 12, 2013
Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptorsJ Robert Lane, Pavel Chubukov, Wei Liu, et al.
Neuropharmacology|March 9, 2026
Differential inhibition of the diverse behavioural effects of mu-opioid receptor agonists by progressive receptor depletionLauren Brown, Cory Langreck, Frances Hough, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
International Orthopaedics|April 23, 2013
Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysisAllison J Rao, Stefan Zwingenberger, Roberto Valladares, et al.
Journal of Medicinal Chemistry|October 22, 2013
A structure-activity analysis of biased agonism at the dopamine D2 receptorJeremy Shonberg, Carmen Klein Herenbrink, Laura López, et al.
Transfusion|September 24, 2004
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteriaLily Lin, Roberta Dikeman, Barbara Molini, et al.
The Journal of Biological Chemistry|February 12, 2010
Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residuesVeli-Pekka Jaakola, J Robert Lane, Judy Y Lin, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
Journal of Medicinal Chemistry|December 31, 2025
Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide ReceptorGeorge J Farmer, Julie Sanchez, Annabell Millns, et al.
Nature Communications|October 4, 2017
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D<sub>2</sub> receptorsDavid A Sykes, Holly Moore, Lisa Stott, et al.
European Urology Focus|November 10, 2019
Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_ScoreNiranjan J Sathianathen, Robert Lane, Benjamin Condon, et al.
Molecular Pharmacology|September 12, 2013
Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptorsJ Robert Lane, Pavel Chubukov, Wei Liu, et al.
Neuropharmacology|March 9, 2026
Differential inhibition of the diverse behavioural effects of mu-opioid receptor agonists by progressive receptor depletionLauren Brown, Cory Langreck, Frances Hough, et al.
Pageof 15